The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Frequently asked Low Dose Naltrexone (LDN) Questions #4 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Frequently asked Questions #5 answered by our Medical Advisors and Medical Members
A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study
Pharmacoepidemiol Drug Saf
26 September 2016
http://onlinelibrary.wiley.com/doi/10.1002/pds.4110/full
Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 (Study)
Pilot study into low dose naltrexone (LDN) and NAD+ for treatment of patients with post-COVID-19 syndrome (Study)
https://clinicaltrials.gov/ct2/show/NCT04604704
This study will assess the use of low dose naltrexone (LDN) and NAD+ for the treatment of patients with post-COVID-19 syndrome (long-COVID-19).
Yoon Hang "John" Kim, MD - Getting the most of LDN treatment and Beyond LDN (2019 Conference) (LDN, low dose naltrexone)
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
BMC Medicine
15 January 2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0
Dana Keaton, ND - Patient selection and inflammation (2019 Conference) (LDN, low dose naltrexone)
Dr. Dana Keaton, Patient selection and inflammation